August 31, 2017 / 8:13 PM / 3 months ago

BRIEF-Aviragen Therapeutics reports Q4 loss per share $0.15

Sept 1 (Reuters) - Aviragen Therapeutics Inc

* Aviragen therapeutics reports fourth quarter and fiscal year 2017 financial results

* Q4 loss per share $0.15

* Q4 revenue $100,000 versus $600,000

* Q4 revenue view $667,000 -- Thomson Reuters I/B/E/S

* Q4 earnings per share view $-0.19 -- Thomson Reuters I/B/E/S

* Aviragen Therapeutics Inc - ‍ Is actively engaged, with assistance of its financial advisor, in evaluating strategic alternatives​

* Aviragen Therapeutics Inc - ‍ Put all activities related to BTA585 program on hold until completion of company’s strategic review process​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below